NCT06925204 Natural Course and Therapeutic Effect of Chronic Pancreatitis
| NCT ID | NCT06925204 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Changhai Hospital |
| Condition | Chronic Pancreatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2025-04-13 |
| Primary Completion | 2035-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2025-04-13 with a primary completion date of 2035-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to establish a prospective cohort of chronic pancreatitis (CP) patients to provide evidence-based guidance for clinical practice and comprehensively optimize diagnostic and treatment strategies. The study aims to collect detailed demographic information, clinical data, medical imaging, biological samples, and follow-up information from CP patients.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with chronic pancreatitis. Exclusion Criteria: * Patients who refuse to sign informed consent.
Contact & Investigator
Zhaoshen Li, M.D.
STUDY CHAIR
Changhai Hospital
Frequently Asked Questions
Who can join the NCT06925204 clinical trial?
This trial is open to participants of all sexes, studying Chronic Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06925204 currently recruiting?
Yes, NCT06925204 is actively recruiting participants. Contact the research team at lianghao-hu@smmu.edu.cn for enrollment information.
Where is the NCT06925204 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06925204 clinical trial?
NCT06925204 is sponsored by Changhai Hospital. The principal investigator is Zhaoshen Li, M.D. at Changhai Hospital. The trial plans to enroll 5,000 participants.